HepaRegeniX

Contact
heparegenix.com
+49 7071 7912810
startup-iconStart-up

HepaRegeniX GmbH

Alfred-Mendler Weg 25/1
89075 Ulm
Germany

Phone

heparegenix.com
Contact
Profile Products News
Contact

About HepaRegeniX

Read more about HepaRegeniX
Facts about HepaRegeniX
  • Founding: 2017
  • Focus : Manufacturer
  • Industry : Biotechnology

Product portfolio of HepaRegeniX

Product portfolio

Show all

News about HepaRegeniX

HepaRegeniX

23-Oct-2024 | people

HepaRegeniX appoints Dr. Martin Bonde as new Chair of the Board

Preparations for upcoming clinical trials in the USA are ongoing

Read news
HepaRegeniX

15-Jul-2024 | business & finance

HepaRegeniX raises €15 million Series C round to advance clinical development of HRX-215 for liver regeneration

Elias Papatheodorou moves from Chair of the Board to CEO of HepaRegeniX

Read news
HepaRegeniX

11-Aug-2021 | research and development

Start-up raises hope in the fight against acute and chronic liver diseases

The biotech company HepaRegeniX, founded in 2017, starts clinical testing of the tolerability of its developed drug in volunteers.

Read news
HepaRegeniX

09-Jul-2020 | business & finance

HepaRegeniX GmbH achieves successful proof of efficacy in acute liver disease models for selected MKK4 inhibitors

Reference to unique potential for the treatment of liver diseases

Read news
HepaRegeniX

23-Jan-2020 | business & finance

€11 Mio. for the treatment of acute and chronic liver diseases

HepaRegeniX secures Series B Financing

Read news
Show more news about HepaRegeniX

Here you will find HepaRegeniX GmbH

Last viewed contents

Liver Cancer: Lipid Synthesis Promotes Tumor Formation

Liver Cancer: Lipid Synthesis Promotes Tumor Formation

Go to page

GenPharmTox erhält FISEA Preis 2004 für gentechnologisch entwickelte in-vitro Verfahren

Go to page